News
A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...
China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-line treatment for CLL and small lymphocytic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback